Literature DB >> 23358304

Implementing an SMS-based intervention for persons living with human immunodeficiency virus.

Jennie L Harris1, Robert Furberg, Nicole Martin, Lisa Kuhns, Megan A Lewis, Curtis Coomes, Peyton Williams, Jennifer D Uhrig.   

Abstract

This article describes a process evaluation conducted as part of a proof-of-concept study to develop, implement, and test a text messaging program to promote medication and appointment adherence, sexual and substance use risk reduction, general health and well-being, social support, and patient involvement. The text-messaging program was implemented in Chicago, Illinois, at an outpatient medical clinic that promotes the well-being of gay, lesbian, bisexual, and transgender persons. We collected and analyzed qualitative data from patients, providers, and research staff to answer the following questions: (1) What factors of the organizational context were important for implementation? (2) How are implementation policies and practices, organizational climate, and perceptions of implementation effectiveness described by intervention stakeholders? (3) What types of issues related to fidelity occurred during implementation? (4) What recommendations for improvement do stakeholders suggest? The study coordinator, providers, and the patients themselves confirmed that patients liked the messages and program overall. The program was implemented with high fidelity. The primary recommendations for improvements were to enhance confidentiality and implement strategies to lessen message fatigue. The findings from this process evaluation demonstrate the feasibility and acceptability of the intervention from the perspectives of patients, providers, and research staff. A larger-scale intervention study that incorporates these stakeholders' suggestions for improvement is warranted.

Entities:  

Mesh:

Year:  2013        PMID: 23358304     DOI: 10.1097/PHH.0b013e3182582b59

Source DB:  PubMed          Journal:  J Public Health Manag Pract        ISSN: 1078-4659


  6 in total

1.  Using a Mobile Health Intervention to Support HIV Treatment Adherence and Retention Among Patients at Risk for Disengaging with Care.

Authors:  Aadia I Rana; Jacob J van den Berg; Eric Lamy; Curt G Beckwith
Journal:  AIDS Patient Care STDS       Date:  2016-04       Impact factor: 5.078

Review 2.  Clients' perceptions and experiences of targeted digital communication accessible via mobile devices for reproductive, maternal, newborn, child, and adolescent health: a qualitative evidence synthesis.

Authors:  Heather Mr Ames; Claire Glenton; Simon Lewin; Tigest Tamrat; Eliud Akama; Natalie Leon
Journal:  Cochrane Database Syst Rev       Date:  2019-10-14

3.  A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial.

Authors:  Katerina A Christopoulos; Elise D Riley; Jacqueline Tulsky; Adam W Carrico; Judith T Moskowitz; Leslie Wilson; Lara S Coffin; Veesta Falahati; Jordan Akerley; Joan F Hilton
Journal:  BMC Infect Dis       Date:  2014-12-31       Impact factor: 3.090

4.  Technical Implementation of a Multi-Component, Text Message-Based Intervention for Persons Living with HIV.

Authors:  Robert D Furberg; Jennifer D Uhrig; Carla M Bann; Megan A Lewis; Jennie L Harris; Peyton Williams; Curtis Coomes; Nicole Martin; Lisa Kuhns
Journal:  JMIR Res Protoc       Date:  2012-11-16

5.  Organizational contextual features that influence the implementation of evidence-based practices across healthcare settings: a systematic integrative review.

Authors:  Shelly-Anne Li; Lianne Jeffs; Melanie Barwick; Bonnie Stevens
Journal:  Syst Rev       Date:  2018-05-05

6.  Behavioral economics-based incentives supported by mobile technology on HIV knowledge and testing frequency among Latino/a men who have sex with men and transgender women: Protocol for a randomized pilot study to test intervention feasibility and acceptability.

Authors:  Sebastian Linnemayr; Sarah MacCarthy; Alice Kim; Rebecca Giguere; Alex Carballo-Dieguez; Joanna L Barreras
Journal:  Trials       Date:  2018-10-05       Impact factor: 2.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.